logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
05/08/2026
Market news: Cuba has stated that the power grid has been restored and is back online following a major blackout.
Latest
1 m ago
Thorne has reached a final acquisition agreement with Procter & Gamble (PG.N).
2 m ago
Market news: The acquisition deal by JPMorgan for the Antin business is expected to bring Idex's enterprise value (including debt) to approximately 3.8 billion, with the transaction potentially announced in the coming days.
2 m ago
US dollar bond fluctuations | The price of Three Gorges Group YANTZE 2.15 09/22/30 rose by 1.147% to 91.658.
2 m ago
Night trading futures closing
2 m ago
Novo Nordisk (NVO.N) raised its earnings forecast for the second time this year due to an increased sales expectation for its obesity and diabetes drugs. Novo Nordisk stated that the adjusted operating profit for the second quarter of 2026 would be 33.389 billion Danish kroner, raising its outlook for the entire year. The largest expected decline in sales and profits this year is anticipated to be 6%, whereas the company had previously estimated that, at constant exchange rates, the decline could reach up to 12%. Novo Nordisk is competing with its rival Eli Lilly (LLY.N) in the obesity market. According to forecasts, this market is expected to grow to $120 billion annually by 2030.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.